http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100222081-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 1997-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2411bdc5bb109f7f025656260ee3f5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aefac0bfcaa76d5d4b976b4c58d30730 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f7ea482ac4e990d0fac99638323de31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac63a43d9d51b88f4d35ccb0b65d901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2122a8ad3a16dbb2b82eebd0ad79374e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14eea981affd15e502897b76739532a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bbfa3bdc07856dc1d5795396d2ab675 |
| publicationDate | 1999-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100222081-B1 |
| titleOfInvention | Quinoline carboxylic acid derivatives with 7- [3-aminomethyl-4- (Z) -substituted oxime] pyrrolidine substituents |
| abstract | The present invention has an excellent antibacterial activity and a broad spectrum of antimicrobial spectrum, and (Z) -4-substituted oximepi as a substituent at the 7-position of the quinolone mother nucleus, which shows pharmacokinetic properties superior to conventional quinolone antibiotics. General formula having a lollidine group A quinoline carboxylic acid derivative in the form of a novel Z-isomer represented by) and a pharmaceutically acceptable salt thereof, a process for its preparation and an antimicrobial composition containing the compound as an active ingredient:n n n n n n n n R is hydrogen, methyl or amino; Q is CH, CF, C-Cl, C-CH 3 , CO-CH 3 or N; R 1 is cyclopropyl, ethyl, or phenyl substituted by one or more fluorine atoms; R 2 is C 1 -C 5 straight or branched alkyl, cyclopropyl, cyclopropylmethyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, haloalkyl, substituted or unsubstituted phenyl or benzyl, or Is a group of general formulas,n n n n n n n n Wherein n is 0 or 1, m is 0, 1 or 2 and X is methylene, O or NH; R 3 and R 4 each independently represent hydrogen or C 1 -C 3 alkyl, or R 3 and R 4 together with the nitrogen atom to which they are attached may form a 5-6 membered heterocycle: |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0168649-A1 |
| priorityDate | 1997-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.